GHK-Cu (50mg)

Endogenous Copper Tripeptide Research Compound

GHK-Cu (50mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

GHK-Cu is a naturally occurring copper tripeptide whose endogenous concentration declines with age — from approximately 200 ng/mL in plasma at age 20 to ~80 ng/mL at 60. This decline is studied in the context of reduced skin thickness, elasticity, and tissue repair capacity. GHK-Cu has one of the broadest activity profiles in the dermal-research literature: collagen synthesis, wound healing, inflammatory signalling, and gene-expression modulation in ageing tissue.

It is the same compound used in cosmetic serums at low topical concentrations. Research-grade lyophilized peptide is supplied for protocols requiring controlled, higher-concentration study.

Key Research Areas

• Collagen & Elastin Synthesis — Studied for stimulating structural protein production in dermal fibroblasts
• Wound Healing — Studied across multiple wound healing models for accelerated epidermal repair
• Dermal Gene Expression — Studied for influence on >4,000 human genes, including repair, renewal, and inflammation pathways
• Inflammation Modulation — Studied for reducing chronic low-grade dermal inflammation

Supplied as lyophilized powder at ≥98% purity, verified by HPLC and mass spectrometry. 50mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.